Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.30 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.30 |
| ▸ | BLM | P54132 | 2/20 | 0.30 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL4368924 | 0.83 | LMNA (0.40) | LMNAALDH1A1TSHRALOX15HSD17B10 | |
| Acrylic Acid SCHEMBL27990010 | 0.79 | LMNA (0.50) | LMNAALDH1A1TSHRALOX15HSD17B10 | |
| Acrylic Acid SCHEMBL29392442 | 0.79 | LMNA (0.56) | LMNAALDH1A1TSHRALOX15HSD17B10 | |
| Acrylic Acid SCHEMBL27472496 | 0.79 | LMNA (0.56) | LMNAALDH1A1TSHRALOX15HSD17B10 | |
| Acrylic Acid SCHEMBL29918659 | 0.79 | LMNA (0.56) | LMNAALDH1A1TSHRALOX15HSD17B10 | |
| Acrylic Acid SCHEMBL29648053 | 0.79 | LMNA (0.56) | LMNAALDH1A1TSHRALOX15HSD17B10 | |
| Acrylic Acid SCHEMBL30556472 | 0.79 | LMNA (0.56) | LMNAALDH1A1TSHRALOX15HSD17B10 | |
| Acrylic Acid SCHEMBL9152411 | 0.78 | — | — | |
| SCHEMBL185900 | 0.78 | — | — | |
| Acrylic Acid SCHEMBL4827349 | 0.77 | LMNA (0.48) | LMNAALDH1A1TSHRALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3095439-B1 | EMULSION COMPOSITION FOR SKIN | OTSUKA PHARMA CO LTD (JP) | 2019-07-17 | — | — | EP | disclosed |
| EP-3095439-A1 | EMULSION COMPOSITION FOR SKIN | Otsuka Pharmaceutical Co., Ltd. (JP) | 2016-11-23 | — | — | EP | disclosed |
| US-20160324737-A1 | EMULSION COMPOSITION FOR SKIN | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2016-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160324737-A1 | EMULSION COMPOSITION FOR SKIN | F12, C1R, CUTA | LMNA 620/4885ALDH1A1 763/4885TSHR 4660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.